Untitled Document
www.expresspharmaonline.com FORTNIGHTLY INSIGHT FOR PHARMA PROFESSIONALS
1-15 December 2007  
Untitled Document
Sections

Market
Management
Research
Pharma Life
Healthcare

Services
Open Forum
Appointments
Subscribe/Renew
Archives
Editorial Calendar
Media Kit
Contact Us
Network Sites
Express Computer
CIO Decisions
Express Channel Business
Express Hospitality
Express TravelWorld
feBusiness Traveller
Exp. Healthcare Mgmt.
Express Textile
Group Sites
ExpressIndia
Indian Express
Financial Express




    MARKET - The Business of Pharmaceuticals
 

Selling stem cells
While adult stem cell therapy currently dominates the global stem cells market with a share of almost 58 percent, the global stem cell market is expected to touch the $20 billion mark by 2010. Sushmi Dey finds out what is happening on the Indian front…

GVK BIO raises Rs 100 crore from Sequoia Capital
GVK Biosciences (GVK BIO), a pharma and biotech research and development outsourcing company, has announced that Sequoia Capital, a global private investment firm has invested Rs 100 crore in the company.

Arch Pharmalabs to acquire majority stake in Avon Organics
The board of directors of Avon Organics passed a resolution at their meeting to allot equity shares on a preferential basis to Arch Pharmalabs at an undisclosed price.

Sanofi Pasteur introduces Pentaxim in India
Sanofi Pasteur, the vaccine division of Sanofi Aventis, has launched Pentaxim, the pentavalent pediatric vaccine in India.

Nicholas Piramal partners with Merck for drug discovery and development
Nicholas Piramal India (NPIL) and Merck, which operates in India through its subsidiary, MSD Pharmaceuticals, has announced a research and development collaboration agreement to discover and develop new drugs for two selected targets provided by Merck.

Argenta and Dr Reddy identify drug candidate for chronic respiratory diseases
Argenta Discovery, a respiratory drug discovery and development company, and Dr Reddy's Laboratories has announced a major milestone in their development programme targeting a novel disease-modifying approach to treat the underlying cause of certain chronic respiratory diseases, including chronic obstructive pulmonary disease (COPD) and severe asthma.

Events

59th API and Interphex China
After Interphex India, its now turn for API and Interphex China. While India and China both have emerging pharmaceutical industries, such exhibitions are always productive for the industry world over. Sushmi Dey surveys the event

Pharma Convention held in Orissa
The first national convention of the Indian Association of Pharmaceutical Scientists and Technologists (IAPST) recently concluded at the beach town of Gopalpur in Orissa.

Three-for-one strategy scores at CPhI, P-MEC, ICSE India
Mumbai recently played host to four days of intense deal-making and information exchange at the co-located CPhI India, P-MEC India and ICSE India. Express Pharma, as the Exclusive Media Partner to the P-MEC show, had a ringside view of the events as they unfolded. We bring you the highlights …


Untitled Document
Untitled Document
© Copyright 2001: Indian Express Newspapers (Mumbai) Limited (Mumbai, India). All rights reserved throughout the world. This entire site is compiled in Mumbai by the Business Publications Division (BPD) of the Indian Express Newspapers (Mumbai) Limited. Site managed by BPD.